基于机制创新的生物医药供应链重组与运营策略

Biopharmaceutical Supply Chain Recombination and Operation Strategy Based on Mechanism Innovation

运用生物技术创新和供应链管理的基本思想,对基于机制创新的生物医药供应链重组与运营策略进行了研究。结果显示:采用公共服务创新平台、"药-械-服务"产品组合创新、基于企业内生比较优势的供应链运营策略细分创新这三类机制创新,可以有效克服生物医药供应链运营的现存缺陷;同时,基于这三类机制创新可以对生物医药供应链进行重组并给出相应的运营策略。

By using the basic idea of biological technology innovation management and supply chain management, this paper researches on the biopharmaceutical supply chain recombination and operation strategy based on mechanism innovation. The result shows that biopharmaceutical supply chain adopting the following three kinds of mechanism innovation can effectively overcome the existing defects of operation, the innovation platform of public service in biopharmaceutical supply chain, the innovation of ＂drug - mechanical - service＂ product combination and the innovation of operation strategy subdivision in biopharmaceutical supply chain based on the enterprises endogenous comparative advantage; At the same time, it can recombines biopharmaceutical supply chain and gives the operation strategy after the reorganization of biopharmaceutical supply chain based on three kinds of mechanism innovation.